Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Biogen 2.736, Vertex Pharmaceuticals 3.334.
Biogen vs Vertex Pharmaceuticals: Revenue Comparison
Biogen (BIIB) and Vertex Pharmaceuticals (VRTX) are peers in Healthcare. Biogen reported revenue of $2.7B as of Q2 2026, compared with $3.3B for Vertex Pharmaceuticals. Vertex Pharmaceuticals leads on revenue.
Biogen's gross margin is 56.9% versus 85.3% for Vertex Pharmaceuticals. Biogen's net margin is 3.6% versus 33.0% for Vertex Pharmaceuticals.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Biogen, Vertex Pharmaceuticals.| Metric | Biogen | Vertex Pharmaceuticals |
|---|---|---|
| Market Cap | - | - |
| Revenue | $2.74B | $3.33B |
| Cost of Revenue | $1.18B | $489.00M |
| Gross Profit | $1.56B | $2.85B |
| Operating Income | $318.00M | $1.25B |
| Net Income | $98.00M | $1.10B |
| R&D Expense | $496.00M | $994.00M |
| Earnings Per Share | $0.66 | $4.31 |
| Gross Margin | 56.9% | 85.3% |
| Operating Margin | 11.6% | 37.4% |
| Net Profit Margin | 3.6% | 33.0% |
| Free Cash Flow | $490.00M | $1.01B |
| Cumulative Free Cash Flow | $47.88B | $17.24B |
| Operating Cash Flow | $449.00M | $1.13B |
| Cash & Equivalents | $1.28B | $6.14B |